Sugiyama T - Search Results

1

Transcriptional and post-transcriptional regulation of βIII-tubulin protein expression in relation with cell cycle-dependent regulation of tumor cells.

Shibazaki M, Maesawa C, Akasaka K, Kasai S, Yasuhira S, Kanno K, Nakayama I, Sugiyama T, Wakabayasi G, Masuda T, Mori N. Shibazaki M, et al. Among authors: sugiyama t. Int J Oncol. 2012 Mar;40(3):695-702. doi: 10.3892/ijo.2011.1291. Epub 2011 Dec 8. Int J Oncol. 2012. PMID: 22159867

2

Aberrant maspin expression in human endometrial cancer.

Murai S, Maesawa C, Masuda T, Sugiyama T. Murai S, et al. Among authors: sugiyama t. Cancer Sci. 2006 Sep;97(9):883-8. doi: 10.1111/j.1349-7006.2006.00266.x. Epub 2006 Jul 4. Cancer Sci. 2006. PMID: 16822296 Free PMC article.

3

Epigenetic modification is involved in aberrant expression of class III beta-tubulin, TUBB3, in ovarian cancer cells.

Izutsu N, Maesawa C, Shibazaki M, Oikawa H, Shoji T, Sugiyama T, Masuda T. Izutsu N, et al. Among authors: sugiyama t. Int J Oncol. 2008 Jun;32(6):1227-35. doi: 10.3892/ijo_32_6_1227. Int J Oncol. 2008. PMID: 18497984

4

DNA damage detected with gammaH2AX in endometrioid adenocarcinoma cell lines.

Ikeda M, Kurose A, Takatori E, Sugiyama T, Traganos F, Darzynkiewicz Z, Sawai T. Ikeda M, et al. Among authors: sugiyama t. Int J Oncol. 2010 May;36(5):1081-8. doi: 10.3892/ijo_00000589. Int J Oncol. 2010. PMID: 20372780 Free PMC article.

5

[Chemotherapy for ovarian cancer].

Sugiyama T, Nagasawa T, Nakayama I. Sugiyama T, et al. Nihon Rinsho. 2012 Jun;70 Suppl 4:594-600. Nihon Rinsho. 2012. PMID: 23156316 Japanese. No abstract available.

6

Loss of HOXD10 expression induced by upregulation of miR-10b accelerates the migration and invasion activities of ovarian cancer cells.

Nakayama I, Shibazaki M, Yashima-Abo A, Miura F, Sugiyama T, Masuda T, Maesawa C. Nakayama I, et al. Among authors: sugiyama t. Int J Oncol. 2013 Jul;43(1):63-71. doi: 10.3892/ijo.2013.1935. Epub 2013 May 13. Int J Oncol. 2013. PMID: 23670532

7

Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.

Itamochi H, Oumi N, Oishi T, Shoji T, Fujiwara H, Sugiyama T, Suzuki M, Kigawa J, Harada T. Itamochi H, et al. Among authors: sugiyama t. Int J Clin Oncol. 2015 Oct;20(5):967-73. doi: 10.1007/s10147-015-0811-x. Epub 2015 Mar 6. Int J Clin Oncol. 2015. PMID: 25744580

8

The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model.

Kagabu M, Yoshino N, Saito T, Miura Y, Takeshita R, Murakami K, Kawamura H, Baba T, Sugiyama T. Kagabu M, et al. Among authors: sugiyama t. Int J Clin Oncol. 2021 Mar;26(3):591-597. doi: 10.1007/s10147-020-01823-6. Epub 2020 Nov 4. Int J Clin Oncol. 2021. PMID: 33146805

9

A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervix.

Takatori E, Shoji T, Suga Y, Niinuma H, Miura Y, Kaido Y, Takada A, Kagabu M, Takeuchi S, Sugiyama T. Takatori E, et al. Among authors: sugiyama t. Int J Clin Oncol. 2014 Apr;19(2):336-40. doi: 10.1007/s10147-013-0539-4. Epub 2013 Mar 14. Int J Clin Oncol. 2014. PMID: 23494222

10

Analysis of prognostic factors for patients with bulky squamous cell carcinoma of the uterine cervix who underwent neoadjuvant chemotherapy followed by radical hysterectomy.

Takatori E, Shoji T, Omi H, Kagabu M, Miura F, Takeuchi S, Kumagai S, Yoshizaki A, Sato A, Sugiyama T. Takatori E, et al. Among authors: sugiyama t. Int J Clin Oncol. 2015 Apr;20(2):345-50. doi: 10.1007/s10147-014-0702-6. Epub 2014 May 14. Int J Clin Oncol. 2015. PMID: 24825458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,911 results

Search Page

Filters